NCT03485313 is a clinical trial in Healthy, sponsored by Response Biomedical Corp..

Who is sponsoring NCT03485313?

NCT03485313 is sponsored by Response Biomedical Corp..

Is NCT03485313 still recruiting?

NCT03485313 is currently terminated. Last updated 25 January 2019.

Last reviewed 2019-01-25 · How we verify

NCT03485313

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beta-hCG Test Reference Range Determination

Terminated Last updated 25 January 2019

What this trial tests

trial in Healthy in 137 participants. Terminated before completion.

Timeline

25 April 2018

Primary endpoint
18 July 2018

29 August 2018

Quick facts

Lead sponsor	Response Biomedical Corp.
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	137
Start date	25 April 2018
Primary completion	18 July 2018
Estimated completion	29 August 2018
Sites	1 location across Canada

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Response Biomedical Corp.

Who can join

18 and older, female only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, single-centre study to determine the reference range (95th percentile) of human chorionic gonadotropin (hCG) levels in a healthy, non-pregnant, adult female population using the RAMP® Total β-hCG test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03485313 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Response Biomedical Corp.
Last refreshed: 25 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03485313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing